Coloplast A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLPBY research report →
About the company
Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Its extensive reach spans Denmark, the United States, the United Kingdom, France, and numerous other international regions. The company's activities are organized into three primary segments: Chronic Care, Interventional Urology, and Wound & Skin Care.
- CEO
- Lars Soren Rasmussen
- IPO
- 2014
- Employees
- 16,741
- HQ
- Humlebæk, DK
Price Chart
- Market Cap
- $13.61B
- P/E
- 42.28
- P/S
- 3.17
- P/B
- 6.93
- EV/EBITDA
- 9.88
- Div Yield
- 5.82%
- Gross Margin
- 58.60%
- Op Margin
- 26.47%
- Net Margin
- 7.51%
- ROE
- 14.23%
- ROIC
- 10.58%
- Revenue
- $26.25B · -2.87%
- Net Income
- $3.42B · -32.21%
- EPS
- $1.52 · -32.37%
- Op Income
- $7.14B
- FCF YoY
- 214.31%
- 52W High
- $10.03
- 52W Low
- $5.64
- 50D MA
- $6.12
- 200D MA
- $7.75
- Beta
- 0.53
- Avg Volume
- 532.52K
Get TickerSpark's AI analysis on CLPBY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CLPBY coverage
Recent articles, reports, and earnings notes.
No research on CLPBY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLPBY report →Similar companies
Peers in the same neighborhood.